Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Overview of Protein Metabolism

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Amino Acid Catabolism

Amino Acid Catabolism

Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adverse pathology and low tumor volume in biopsy Gleason 3 + 4 prostate cancer: Toward safe expansion of active surveillance and focal therapy.

Urologic oncology·2026

Same author

Mytho/Phaf1 is required to prevent DNA damage and tissue degeneration in Danio rerio.

Cell death discovery·2026

Same author

Integrating Genomic Prostate Score with Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores to Predict Biochemical Recurrence after Radical Prostatectomy.

European urology oncology·2026

Same author

Risk factors for seminal vesicle invasion at radical prostatectomy.

World journal of urology·2026

Same author

Human neuromuscular organoids mimic cancer-induced muscle cachexia.

Cell reports methods·2026

Same author

Tumor-associated macrophages enhance peripheral nerve tumor infiltration and spinal cord repair.

Immunity·2026

Search research articles

Related Experiment Video

Updated: Mar 30, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Protein breakdown in cancer cachexia.

¹Venetian Institute of Molecular Medicine (VIMM), Padova, Italy; Department of Biomedical Sciences, University of Padova, Padova, Italy; Institute of Neuroscience, Consiglio Nazionale delle Ricerche (CNR), Padova, Italy; Department of Medicine, McGill University, Montreal, QC, Canada H3AoG4.

Seminars in Cell & Developmental Biology

|November 14, 2015

Summary

This summary is machine-generated.

Cancer cachexia causes muscle loss by disrupting protein balance. This review details how the ubiquitin proteasome and autophagy lysosome systems drive muscle breakdown in cancer.

Keywords:

Atrophy Autophagy Cancer cachexia FoxO Lysosome Muscle Myostatin Proteasome Ubiquitin

More Related Videos

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Experiment Videos

Last Updated: Mar 30, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Area of Science:

Muscle physiology and cellular degradation pathways.

Background:

Skeletal muscle adapts to stimuli but cancer compromises homeostasis, leading to muscle mass loss and functional decline.
Tumor-induced catabolism involves increased muscle protein breakdown to supply amino acids for liver gluconeogenesis and tissue synthesis.

Purpose of the Study:

To review the roles of the ubiquitin proteasome and autophagy lysosome systems in cancer cachexia.
To describe key signaling pathways regulating tumor-induced muscle protein breakdown.

Main Methods:

Literature review of cellular degradation systems and signaling pathways in cancer cachexia.

Main Results:

The ubiquitin proteasome and autophagy lysosome are critical cellular degradation systems implicated in cancer cachexia.
Specific signaling pathways regulate protein turnover and contribute to muscle wasting.

Conclusions:

Understanding the ubiquitin proteasome and autophagy lysosome pathways is crucial for addressing muscle loss in cancer.
Targeting these pathways may offer therapeutic strategies for cancer cachexia.